Spero Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Spero Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Spero Therapeutics Inc
Rating: 1.972055625
Author: Trendlyne DVM scores

Slowing Down Stock

about

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, teb...

1.26 -0.10 (-7.35%)

59.09% Fall from 52W High

1.4M

XNAS Volume

High vol.+gain this week

XNAS 23 Sep, 2026 5:30 PM (EDT)

Medium Financial Strength

38.9 / 100

Mid Valuation

48.7 / 100

Technically Bearish

31.3 / 100

Slowing Down Stock These stocks have medium financials and valuations, but weak momentum indicating decreasing investor interest View Similar Embed DVM

1Yr Price target upside is 297%

2 analysts

Spero Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Spero Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, teb...

59.09% Fall from 52W High

High vol.+gain this week

SWOT Analysis

Spero Therapeutics Inc Live Price Chart

Spero Therapeutics Inc Live Price Chart